Ignite Creation Date:
2025-12-24 @ 10:36 PM
Ignite Modification Date:
2025-12-25 @ 8:08 PM
Study NCT ID:
NCT05972135
Status:
RECRUITING
Last Update Posted:
2025-10-29
First Post:
2023-07-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
Sponsor:
SCRI Development Innovations, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-23
Start Date Type:
ACTUAL
Primary Completion Date:
2027-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-10
Completion Date Type:
ESTIMATED
First Submit Date:
2023-07-12
First Submit QC Date:
None
Study First Post Date:
2023-08-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-28
Last Update Post Date:
2025-10-29
Last Update Post Date Type:
ESTIMATED